Shares of Synageva BioPharma (GEVA) reverse an AH decline yesterday that followed its announcement of a $60M stock offering, gaining 12.8% today to touch 52-week highs.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs